Filter results
You can narrow down the results using the filters
Audience
Topics
Our work
Diseases
Year
      572 results
    
    - 
  
    
  
Budget 2020–21 – implementation of roadmap for hearing healthA collection of fact sheets on the implementation of a roadmap for hearing health from the 2020–21 Budget.
- 
  
    
  
Wellness and reablement resourcesOur collection of practical guides and tools for aged care providers will help you embed wellness and reablement approaches into your service delivery.
- 
  
    
  
National Bowel Cancer Screening Program – FormsThese forms are for healthcare providers. By completing them, it helps ensure participant data completeness in the National Cancer Screening Register.
- 
  
    
  
Stoma Product Assessment Panel public summary documents – October 2020 meetingThis collection lists documents that summarise recommendations that the Stoma Product Assessment Panel's made after assessing products for the Stoma Appliance Scheme Schedule at its April 2020 meeting.
- 
  
    
  
Coronavirus (COVID-19) social and emotional wellbeing resources for Aboriginal and Torres Strait IslandersFind out how you can share important messages around social and emotional wellbeing.
- 
  
    
  
National Mental Health Workforce Strategy Taskforce communiquesCommuniques for the 2020 and 2021 meetings of the National Mental Health Workforce Strategy Taskforce.
- 
  
    
  
MBS Review – Final taskforce reports, findings and recommendationsThis collection contains all the final reports, findings and recommendations from the Medicare Benefits Schedule (MBS) Review Taskforce to the Australian Government.
- 
  
    
  
National COVID-19 Aged Care PlanThis collection contains the updated 7th edition of the National COVID-19 Aged Care Plan, as well as several publications designed to be read in conjunction with the plan.
- 
  
    
  
Vaccine safety in Australia – AusVaxSafety 2019This collection contains the Vaccine safety in Australia AusVaxSafety summary report 2019 and related infographics.
- 
  
    
  
Practitioner Review Program – Health professional guidelinesThese guidelines help you to understand what documents can be used to substantiate services if you are asked to participate in a compliance audit or review.
- 
  
    
  
Stoma Product Assessment Panel public summary documents – October 2019This collection lists documents that summarise recommendations that the Stoma Product Assessment Panel's made after assessing products for the Stoma Appliance Scheme Schedule at the October 2019 meeting.
- 
  
    
  
Stoma Product Assessment Panel public summary documents – November 2019 out of sessionThis collection lists documents that summarise recommendations that the Stoma Product Assessment Panel's made after assessing products for the Stoma Appliance Scheme Schedule out of session in November 2019.
- 
  
    
  
Life Saving Drugs Program resources – Mucopolysaccharidosis type I (MPS I)A collection of resources for health professionals to help people with mucopolysaccharidosis type I (MPS I) access laronidase (Aldurazyme®) under the Life Saving Drugs Program.
- 
  
    
  
Life Saving Drugs Program resources – Mucopolysaccharidosis type II (MPS II)A collection of resources for health professionals to help people with mucopolysaccharidosis type II (MPS II) access idursulfase (Elaprase®) under the Life Saving Drugs Program.
- 
  
    
  
Life Saving Drugs Program resources – Mucopolysaccharidosis type IVA (MPS IVA)A collection of resources for health professionals to help people with mucopolysaccharidosis type IVA (MPS IVA) access elosulfase alfa (Vimizim®) under the Life Saving Drugs Program.
- 
  
    
  
Life Saving Drugs Program resources – Mucopolysaccharidosis type VI (MPS VI)A collection of resources for health professionals to help people with mucopolysaccharidosis type VI (MPS VI) access galsulfase (Naglazyme®) under the Life Saving Drugs Program (LSDP).
- 
  
    
  
Life Saving Drugs Program resources – Pompe diseaseA collection of resources for health professionals to help people with Pompe disease access alglucosidase alfa (Myozyme®) and avalglucosidase alfa (Nexviazyme®) under the Life Saving Drugs Program.
- 
  
    
  
Life Saving Drugs Program resources – Hereditary tyrosinaemia type 1A collection of resources for health professionals to help people with hereditary tyrosinaemia type 1 access nitisinone (Orfadin® and Nityr™) under the Life Saving Drugs Program.
- 
  
    
  
Life Saving Drugs Program resources – Late-Infantile onset batten disease (CLN2 disease)A collection of resources for health professionals to help people with CLN2 disease access cerliponase alfa (Brineura®) under the Life Saving Drugs Program.
- 
  
    
  
Life Saving Drugs Program resources – Fabry diseaseA collection of resources for health professionals to help people with Fabry disease access the following drugs under the Life Saving Drugs Program: agalsidase alfa (Replagal®), agalsidase beta (Fabrazyme®).
- 
  
    
  
Stoma Product Assessment Panel public summary documents – April 2020 meetingThis collection lists documents that summarise recommendations that the Stoma Product Assessment Panel's made after assessing products for the Stoma Appliance Scheme Schedule at its April 2020 meeting.
- 
  
    
  
Stoma Appliance Scheme utilisation and expenditure data collectionDocuments in this collection show how much we spent each financial year on stoma appliances and products under the Stoma Appliance Scheme.
- 
  
    
  
Budget 2020–21Fact sheets and other health, aged care and sport information from the 2020–21 Budget.
- 
  
    
  
Budget 2020–21: Guaranteeing Medicare and access to medicinesA collection of fact sheets from the 2020–21 Budget.
- 
  
    
  
Budget 2020–21: Prioritising mental health, preventive health and sportA collection of fact sheets from the 2020–21 Budget.